Member Info for LovableLumax

peddling here? i used the dec 31 figure of £6.1m and as the co said they’d run out of money in august my calcs made sense. i don’t constantly post immaterial linkedin nonsense. you have fewer than 50 contacts so clearly don’t understand the platform. you thought invoice financing on the cards due to a linkedin like from a guy working at such a co. you’ve peddled absolute bull for many months and egged on people to buy at double the current share price. you ******* clown.

as for lotm, just has bad. apologies for telling all to buy before the inevitable raise and is back pumping.

No doubt 2phevs and LOtM will be pumping hard as both underwater and lap up the jam tomorrow nonsense. Given the cash position and guidance they will be raising early next year. That will hopefully be the last one to get them to profit but the auditor will need sufficient cash to sign off accounts. Q1 raise

Phew, was anxious you would not keep us all updated. I have noted the purchase for my records. Thanks.

So they are selling shares below mid which is not good and feck all volume.

there is not an rns blackout, there are no rnss as these campaigns or brand partnerships are not material so will not contribute £180k or 10% of last year's revenue. they have posted many things on linkedin over the years which haven't been subject to an rns as contribute little cash which the **** poor revenues testify.

oh and 2phevs was sure a raise not needed as a guy from an invoice lending co liked a post of mirriad’s/the ceo’s. funny as ****

The CEO takes £500k a year and has less than 1.5m shares FFS. He’s done well to eke out another pay cheque. Jan tomorrow.

It’s best to do your own research as 2phevs is pumping this ludicrously as is sadly over £50k down. He can’t even do sums.

Cash as at Dec 31 was £6.1m and the co said they would run out of money in August. If they made it to 31 Aug they are burning £762,500 a month so I assume they’ll make it to mid month so around £800k a month cash burn. Remember 2phevs tried to convince others mirriad could get cash via future invoices so could avoid a raise. Funny as. Billing say £150k a month but burning over 5 times that, yeah a great debtor to have on your books!

Potential massive but cash burn, crap pipeline means a raise needed early next year to avoid what happened this year. Its obvious.

It's oversold here and due a bounce, RSI etc all way down so surely a bounce en route shortly

To be fair not the number they have shorted but if there was a concerted effort which collapsed the share price, exacerbated by CLNs and the co couldn't raise money so went under it would. Not the case here as just raised and hopefully deals being closed etc. Can seriously hinder some PLCs though. Just be funny to embarrass the guy

Should make a tiny donation in order to put a message on his page - unbelievable you're raising money for cancer when shorting a company developing kinder and more targeted cancer therapies.

Their report says ads are fine when managed and timed properly as the title of the article suggests -

It’s Not The Ads, It’s How They’re Delivered.

To reduce the appearance of unnatural ad breaks, advertisers are urged to prioritize working with publishers who use advanced technology tools for advertising management, like AI, to better understand where best to place ad breaks within the content, solving for some of the unnatural ad breaks.

2Phevs again demonstrates why he shouldn't be investing. They could not only raise enough until the end of the year or they would have to come off the AIM due to the auditor not signing the accounts off. Again, I told you this before the raise. Are you incapable of listening to important info or do you believe immaterial news on LinkedIn better? They were going to run out of cash in August so were desperate. I hope they have learnt to will raise in Jan next year rather than last minute. Remember H2 stronger and guidance this year not great so next year H1 poor cash needed and then hopefully that's it as programmatic kicks off

Is surprising, enough cash for likely 12 months but the market expects (given poor pipeline and broker guidance) another raise H1 next year or the auditor won't sign the accounts off. People have wised up to MIRI posting many impressive parternships and campaigns on LinkedIn but they are not material as they are not subject to an RNS. That said I still expect a short term rally above placing and maybe to 2p before lots of dumping (churning placement shares) and then sub 1p. It happened last time and I'm sure some rampy news will drop soon to get people buying in.

*whereas all of these very ill , end of life patients would have got very ill receiving straight dox which is an awful

Way to spend your last months.

I would say all the patients and their clinicians would rather they receoced AVA6000 than dox. Most of them have had several prior treatments, tumours not sensitive to dox and tumours that are refractory so giving them straight dox would have had little impact on tumour (6000 delivers in higher concentrations) whilst with 6000 we have some taking drug for many months (dox onky 6 cycles over 4.5 months) and of course little side effects whereas all of these very ill end of list patients would have got very will receiving straight dox.

Give 6000 as a first line treatment to tumours sensitive to dox and winner winner. Assuming of course the chemistry continues to work and lots of dox in tumours whilst little systemically.

LOTM if you're going to copy what I write at least understand and spell the term properly. FYI the below is tautological -

given that fait accomplice had already been achieved as far as they were concerned .

*This is what I wrote to LOTM on ADVFN a few days ago

I wonder how long LOTM has been investing and he seems naive as feck and also continues to copy what I write as 2Phevs has on occasion. Good to see they slowly learn.

This is what I wrote to LOTM on LSE -

LOTM I informed you it was not a meeting for shareholders as it’s a fait accompli and questions not welcome. You would have been intentionally shown the wrong room. They would have asked reception to do so. Your naivety something else. I guess that’s why you were egging people on to buy before the raise as I doubt you were being disingenuous. You need to scan back and you’ll see years of LinkedIn posts that are not subject to RNSs as they are not material hence crap revenue, high cash burn and crap pipeline.

They’ve worked with Lexus for a few years. The partnership has meant tiny revenues. Any partnership worth 10% of previous year’s revenue has to be subject to an RNS, these don’t. They don’t RNS every poxy campaign or they would burn cash even more quickly as each one is paid for!

Phevs over £50k down so will continue to pump and try and attract buyers in Order to exit. He’s been there and done that!

Currently burning £800k a month, pipeline crap and broker guidance crap. Raise Q1 next year.

Isn't it a little tiresome to repeat the same stuff day in day out. We know timelines have been missed and substantially but we planned to have 12 patients and 4 cohorts in P1 and we needed sign off to go to 7 cohorts and ended up having 42 patients. We are also trialing 2 weekly and have the ability to dose as a first line treatment as the data has allowed this. What's the point in repeating the same old stuff unless you have an an agenda or nothing else to do which is sad. We had some decent posts over the weekend and some decent links which will be lost by the usual posters waffling on and patting themselves on the back. Get a life FFS.